Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Tong X, Li K, Luo Z, Lu B, Liu X, Wang T, Pang M, Liang B, Tan M, Wu M, Zhao J, Guo Y.

Am J Pathol. 2009 May;174(5):1931-9. doi: 10.2353/ajpath.2009.080846. Epub 2009 Apr 6.

2.

Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.

Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J, Guo Y.

Int J Cancer. 2014 Mar 15;134(6):1369-78. doi: 10.1002/ijc.28471. Epub 2013 Oct 3.

3.

Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.

Zhao J, Lu B, Xu H, Tong X, Wu G, Zhang X, Liang A, Cong W, Dai J, Wang H, Wu M, Guo Y.

Hepatology. 2008 Jul;48(1):265-75. doi: 10.1002/hep.22280.

PMID:
18537194
4.

TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.

Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F, Yan X, Lu B, Xu H, Guo Y.

Hum Pathol. 2007 Feb;38(2):293-8. Epub 2006 Nov 13.

PMID:
17097132
5.

ADAM8 as a novel serological and histochemical marker for lung cancer.

Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y.

Clin Cancer Res. 2004 Dec 15;10(24):8363-70.

6.

Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.

Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.

Tumour Biol. 2016 Jul;37(7):9979-87. doi: 10.1007/s13277-016-4896-2. Epub 2016 Jan 27.

PMID:
26819207
7.

Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.

Zhu M, Yin F, Fan X, Jing W, Chen R, Liu L, Zhang L, Liu Y, Liang Y, Bu F, Tong X, Zheng H, Zhao J, Guo Y.

Oncogene. 2015 Mar 12;34(11):1420-31. doi: 10.1038/onc.2014.73. Epub 2014 Mar 31.

PMID:
24681951
8.

MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.

Yang Y, Liu L, Zhang Y, Guan H, Wu J, Zhu X, Yuan J, Li M.

Int J Cancer. 2014 Oct 1;135(7):1531-42. doi: 10.1002/ijc.28799. Epub 2014 Mar 27.

9.

TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.

Bu F, Liu X, Li J, Chen S, Tong X, Ma C, Mao H, Pan F, Li X, Chen B, Xu L, Li E, Kou G, Han J, Guo S, Zhao J, Guo Y.

Oncotarget. 2015 Feb 10;6(4):2120-33.

10.

Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.

Zhao B, Sun T, Meng F, Qu A, Li C, Shen H, Jin Y, Li W.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1061-70. doi: 10.1007/s00432-010-0968-7. Epub 2011 Jan 5.

PMID:
21207061
11.

microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.

Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R.

J Cancer Res Clin Oncol. 2015 Mar;141(3):431-41. doi: 10.1007/s00432-014-1836-7. Epub 2014 Sep 23.

PMID:
25245053
12.

Pathobiological implications of MUC4 in non-small-cell lung cancer.

Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, Ganti AK.

J Thorac Oncol. 2013 Apr;8(4):398-407. doi: 10.1097/JTO.0b013e3182829e06.

13.

TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice.

Li A, Zhang C, Gao S, Chen F, Yang C, Luo R, Xiao H.

Oncogene. 2013 May 2;32(18):2273-81, 2281e.1-12. doi: 10.1038/onc.2012.253. Epub 2012 Jun 25.

14.

Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, Chen JF, Zhang EB, De W, Wang ZX.

Mol Cancer. 2014 Mar 21;13:68. doi: 10.1186/1476-4598-13-68.

15.

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.

Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, Motohashi S, Yokoi S, Hiroshima K, Tagawa M, Nakayama T, Fujisawa T.

Cancer Immunol Immunother. 2004 Sep;53(9):786-92. Epub 2004 Jun 4.

PMID:
15185009
16.

Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.

Chen P, Yu J, Knecht J, Chen Q.

Cancer Epidemiol. 2013 Apr;37(2):166-71. doi: 10.1016/j.canep.2012.12.004. Epub 2013 Jan 10.

PMID:
23312889
17.

Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.

18.

Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.

Li X, Wan L, Geng J, Wu CL, Bai X.

J Thorac Oncol. 2012 Aug;7(8):1235-45. doi: 10.1097/JTO.0b013e318257cc6d.

19.

Differential expression of RON in small and non-small cell lung cancers.

Kanteti R, Krishnaswamy S, Catenacci D, Tan YH, EL-Hashani E, Cervantes G, Husain AN, Tretiakova M, Vokes EE, Huet H, Salgia R.

Genes Chromosomes Cancer. 2012 Sep;51(9):841-51. doi: 10.1002/gcc.21968. Epub 2012 May 14.

PMID:
22585712
20.

delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.

Zhang JY, Wang Y, Zhang D, Yang ZQ, Dong XJ, Jiang GY, Zhang PX, Dai SD, Dong QZ, Han Y, Zhang S, Cui QZ, Wang EH.

J Pathol. 2010 Sep;222(1):76-88. doi: 10.1002/path.2742.

PMID:
20593408

Supplemental Content

Support Center